CHV
Boston, Massachusettschv.vc
Overview
Catalyst Health Ventures (CHV) is a venture capital fund investing in transformative medical technologies addressing global unmet needs. They focus on investment opportunities within the healthcare and life science markets, specifically medical technologies including medical devices, diagnostics, drug delivery, and digital health. They are typically the first institutional investor and support companies through early product and clinical development and often through the regulatory process.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AtaCor Medical | Apr 2024 | Series C | Co-investor |
| Instylla | Aug 2023 | Series B Extension | Co-investor |
| Instylla | Oct 2020 | Series B | Lead |
| Conformal Medical | Aug 2020 | Series C | Lead |
| AtaCor Medical | Apr 2020 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.